3 insiders reported 5 Form 4 transactions for Astria Therapeutics, Inc. (ATXS) over the past 18 months (most recent 2026-01-23). Recent activity: Milne Jill C. (CEO and President) Sell 4,377 shares, Violin Jonathan (Director) Sell 263,321 shares, Komjathy Andrew (Chief Commercial Officer) Sell 10 shares, Komjathy Andrew (Chief Commercial Officer) Sell 45 shares, Komjathy Andrew (Chief Commercial Officer) Sell 45 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-23 | Milne Jill C. | CEO and President | Sell | 4,377 | $0 |
| 2026-01-23 | Violin Jonathan | Director | Sell | 263,321 | $0 |
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 10 | $0 |
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 45 | $0 |
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 45 | $0 |
Source: SEC Form 4 filings · as of 2026-01-23
